Insider Buying: Leroy Kopp Acquires 9,000 Shares of Transgenomic Stock (TBIO)
Transgenomic (NASDAQ:TBIO) major shareholder Leroy Kopp acquired 9,000 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were purchased at an average cost of $0.39 per share, with a total value of $3,510.00. Following the completion of the transaction, the insider now directly owns 4,956,600 shares of the company’s stock, valued at approximately $1,933,074. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Transgenomic (NASDAQ:TBIO) traded up 8.70% on Friday, hitting $0.50. 828,497 shares of the company’s stock traded hands. Transgenomic has a one year low of $0.30 and a one year high of $0.97. The stock has a 50-day moving average of $0.37 and a 200-day moving average of $0.39. The company’s market cap is $44.1 million.
Transgenomic, Inc is a biotechnology company operates in two segments: Clinical Laboratories, Pharmacogenomics Services and Diagnostic Tools.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.